In part five of this roundtable, the panel shares insights on sequencing strategies, the challenges of balancing efficacy with bone marrow preservation, and the promise of precision medicine. They also discuss the potential of immunotherapy in prostate cancer and the transformative impact of prevention and risk-adapted screening strategies, sharing valuable perspectives for clinicians navigating advanced and castration-resistant prostate cancer care.